glp 1 agonist tirzepatide GLP-1 use tripled among non-diabetics, reaching $5.8B in 2022 𝗧𝗵𝗲 𝗘𝗳𝗳𝗲𝗰𝘁 𝗼𝗳 𝗚𝗟𝗣-𝟭 𝗥𝗲𝗰𝗲𝗽𝘁𝗼𝗿

Looking beyond GLP-1 receptor mono-agonists, the design of future incretin-based peptide therapies is destined to provide multifunctional capability, such that a single peptide can interact with several different receptors to create a broad portfolio of effects [37]

Weight Regain Timeline After Stopping Semaglutide Most people begin regaining weight within weeks of stopping semaglutide, with the steepest increases occurring in the first 2-3 months

Sugary drinks, artificial sweeteners (sorbitol, maltitol), and carbonated beverages create gas and stomach pressure

This medication can help individuals achieve weight loss goals by suppressing their appetite and providing a feeling of fullness, leading to reduced caloric intake

References Hiwasa, T

This peptide focuses on both weight AND fat loss by working in two different paths